	A PML1-CCL5-PI3K/MAPK feedback loop governs survival of endocrine-resistant breast cancer cells. Cell Death Differ Wang H, Yun Z, Cao Y, Li X, Liu Z, Pai CP, Wu C, Yue J, Lin G, Cai J, Fang S, Li K, Willard B, Yang S, Keri RA, Schiemann WP, Diehl JA, Kao HY. PMID: 42260104 [PubMed - as supplied by publisher]
	First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial. Nat Cancer Schmid P, Im SA, Nowecki Z, Wysocki PJ, Jassem J, Jung KH, Lord S, Armstrong J, Stewart R, Vukovi, Denduluri N, Park YH. PMID: 42259988 [PubMed - as supplied by publisher]
	International consensus on axillary staging after neoadjuvant chemotherapy in node-positive breast cancer. Eur J Surg Oncol Lucocq J, Karakatsanis A, Kirwan C, Boughey J, Tseng J, Sun SX, Gentilini OD, Barber M, Chagla L, Buccimazza I, Dick L, Massannat Y, Dixon JM, Kühn T, Benson J, Elder K, NAC-AX Collaborative Group. PMID: 42259722 [PubMed - as supplied by publisher]
	Combined targeting of mesothelin and tenascin-C enhances CAR-T cell function and tumor microenvironment modulation in ovarian cancer. Mol Immunol Wang X, Zhang D, Wang T, Li X, Zhang J. PMID: 42259008 [PubMed - as supplied by publisher]
	Psychometric evaluation of the NFOSI-18 disease related symptoms - Physical, NFOSI-18 Total, and FACT GP5 in the recurrent ovarian cancer phase III study GY004. Gynecol Oncol Tang X, Huang H, Peipert JD, Zola A, Buscema J, Yang K, Tew W, O'Cearbhaill RE, Muller C, Goodheart MJ, Moore RG, Liu R, Geller MA, Michener C, Chan J, Carney M, McNally L, Street D, Bookman MA, Moore KN, Liu JF, Wenzel L, Cella D. PMID: 42258989 [PubMed - as supplied by publisher]
	Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer. ESMO Open Salehi E, Chu X, Mayer EL, Singer S, Augdahl G, Stalteri M, Li T, Dibble KE, Sinclair N, Faggen M, Walsh J, Sammons S, Sendrick K, Hanna S, Mostaghimi A, Tayob N, LeBoeuf NR, Tolaney SM. PMID: 42258966 [PubMed - as supplied by publisher]
	Comparison of long-term survival between primary and interval cytoreductive surgery in advanced ovarian cancer: A ten-year real-world cohort study. Eur J Surg Oncol Duan X, Tan S, Wang C, Liu J, Huang L, Zhang Y. PMID: 42258952 [PubMed - as supplied by publisher]
	Headwinds in Breast Cancer Research: The Case for Pragmatic Radiotherapy De-escalation Studies. J Clin Oncol Braunstein LZ, Mitchell MP, Khan AJ, Sikov WM, Mamounas EP, Julian TB, Wolmark N. PMID: 42258793 [PubMed - as supplied by publisher]
	The use of menopause hormone therapy in borderline ovarian tumor survivors: a systematic review and meta-analysis. Climacteric Mejia-Gomez J, Tigert M, Jacobson M, Shprits E, Shea AK, Philippopoulos E, Kotsopoulos J, Bridger A, Sanchez Diaz N, Puveendrakumaran P, Shaltout N, Benipal H, Sosea C, Leslie B, Garzon A, Wolfman W, Zigras T. PMID: 42258345 [PubMed - as supplied by publisher]
	SAFE-IOERT prospective study: clinical outcomes of exclusive intraoperative radiotherapy in early breast cancer according to molecular subtype and tumor-infiltrating lymphocytes. Clin Transl Oncol Oses G, Clavell C, González-Farré B, Sanfeliu E, Laplana M, Martínez A, Moreno S, Meca G, Gomis E, Carreras-Ballvé J, Mension E, Cebrecos I, Caparrós X, Tarrats-Rosell J, Cases C, Herreros A, Mollà M. PMID: 42258139 [PubMed - as supplied by publisher]
	Withaferin A in breast cancer therapy: multi-targeted modulation of redox homeostasis, autophagy, and apoptosis. J Asian Nat Prod Res Patel N, Gupta A, Mishra R, Pandey SN, Goyal K, Ali H, Maji C, Rekha A, Hussain MS, Singh SK, Gupta G. PMID: 42257714 [PubMed - as supplied by publisher]
	Dynamic breast magnetic resonance imaging features and pathological correlation of patients diagnosed with breast cancer under the age of 40. Acta Radiol Gundogdu V, Meltem E, Ulusan MB, Bozkurt H, Mahmutoglu AS. PMID: 42257534 [PubMed - as supplied by publisher]
	Ipsilateral Breast Tumor Detected 20 Years after Occult Breast Cancer: A Diagnostic Challenge in Distinguishing New Primary Cancer from Late Recurrence. Case Rep Oncol Masuda Y, Tanaka M, Koga Y, Eto K, Watanabe R, Yoshinaga Y, Satou T. PMID: 42257037 [PubMed]
	Non-pharmacological sleep management in breast cancer survivors: Evidence from a systematic review and meta-analysis of RCTs. Prev Med Rep Aemmi SZ, Mohammadi-Pirouz Z, Moradi M. PMID: 42256805 [PubMed]
	Financial incentives for women's cervical, breast and colorectal cancer screening adherence: systematic review and meta-analysis. Prev Med Rep Lumia C, Nespoli A, Ausili D, Fumagalli S, Dumont A. PMID: 42256798 [PubMed]
	The Effect of a Program Based on the Common-Sense Model on Illness Perception and Health-Promoting Behaviors in Women with Breast Cancer: A Randomized Clinical Trial Study. Iran J Nurs Midwifery Res Bahrami M, Musarezaie A, Alidousti F. PMID: 42256750 [PubMed]
	Uterine Cervical Cancer: Diagnostic Accuracy of Clinical Staging, Magnetic Resonance Imaging, and Histopathology Findings. Iran J Nurs Midwifery Res Allameh FZ, Sabet F, Behnamfar F, Seresht LM, Amini S. PMID: 42256744 [PubMed]
	Assessing the hepatic and renal parameters of breast cancer patient blood samples before and after chemotherapy. Toxicol Rep Heilat GB, Alwidyan T, Alrosan AZ, Rataan AO, Alrosan K, Ahmad RB, Al-Kammash KR. PMID: 42255660 [PubMed]
	Existing and emerging strategies for fertility preservation in female patients with leukemia. Front Endocrinol (Lausanne) Abazarikia A, Purkayastha A, So W, Rasekhi M, Kim SY. PMID: 42255431 [PubMed - indexed for MEDLINE]
	Peripheral blood monocytes could be associated with brain metastasis and affect patient prognosis in breast cancer: a retrospective study. Front Oncol Yoo J, Park HH, Kim SY, Ahn SJ, Ahn J, Oh J, Lim J. PMID: 42255246 [PubMed]

Articles 1 - 20 / 329770

Page 1 of 16489



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy